Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
RSC Chemical Biology
|
February 7, 2022
Stapling proteins in the RELA complex inhibits TNFα-induced nuclear translocation of RELA
Smit Kour, Sandeep Rana, Smitha Kizhake, et al.
RSC Medicinal Chemistry
|
May 30, 2023
<i>Mycobacterium tuberculosis</i> CitA activity is modulated by cysteine oxidation and pyruvate binding
Rasangi Pathirage, Lorenza Favrot, Cecile Petit, et al.
Neuropeptides
|
December 29, 2015
Synthesis and binding characteristics of [(3)H]neuromedin N, a NTS2 receptor ligand
Fanni Tóth, Jayapal Reddy Mallareddy, Dirk Tourwé, et al.
Communications Biology
|
December 31, 2024
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
Ezequiel J Tolosa, Lin Yang, Jennifer Ayers-Ringler, et al.
European Journal of Pharmacology
|
February 5, 2013
[3H]IVDE77, a novel radioligand with high affinity and selectivity for the insulin-regulated aminopeptidase
Alexandros Nikolaou, Isabelle Van den Eynde, Dirk Tourwé, et al.
Frontiers in Pharmacology
|
June 1, 2022
Systemic Administration of a Brain Permeable Cdk5 Inhibitor Alters Neurobehavior
Alan Umfress, Sarbjit Singh, Kevin J Ryan, et al.
Hemato
|
October 25, 2024
The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax
Alexandria P Eiken, Elizabeth Schmitz, Erin M Drengler, et al.
European Journal of Medicinal Chemistry
|
June 7, 2021
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy
Satish Sagar, Sarbjit Singh, Jayapal Reddy Mallareddy, et al.
The Journal of Biological Chemistry
|
April 4, 2022
Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells
Smit Kour, Sandeep Rana, Sydney P Kubica, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 25, 2021
Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax
Hannah M King, Sandeep Rana, Sydney P Kubica, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
RSC Chemical Biology
|
February 7, 2022
Stapling proteins in the RELA complex inhibits TNFα-induced nuclear translocation of RELA
Smit Kour, Sandeep Rana, Smitha Kizhake, et al.
RSC Medicinal Chemistry
|
May 30, 2023
<i>Mycobacterium tuberculosis</i> CitA activity is modulated by cysteine oxidation and pyruvate binding
Rasangi Pathirage, Lorenza Favrot, Cecile Petit, et al.
Neuropeptides
|
December 29, 2015
Synthesis and binding characteristics of [(3)H]neuromedin N, a NTS2 receptor ligand
Fanni Tóth, Jayapal Reddy Mallareddy, Dirk Tourwé, et al.
Communications Biology
|
December 31, 2024
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
Ezequiel J Tolosa, Lin Yang, Jennifer Ayers-Ringler, et al.
European Journal of Pharmacology
|
February 5, 2013
[3H]IVDE77, a novel radioligand with high affinity and selectivity for the insulin-regulated aminopeptidase
Alexandros Nikolaou, Isabelle Van den Eynde, Dirk Tourwé, et al.
Frontiers in Pharmacology
|
June 1, 2022
Systemic Administration of a Brain Permeable Cdk5 Inhibitor Alters Neurobehavior
Alan Umfress, Sarbjit Singh, Kevin J Ryan, et al.
Hemato
|
October 25, 2024
The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax
Alexandria P Eiken, Elizabeth Schmitz, Erin M Drengler, et al.
European Journal of Medicinal Chemistry
|
June 7, 2021
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy
Satish Sagar, Sarbjit Singh, Jayapal Reddy Mallareddy, et al.
The Journal of Biological Chemistry
|
April 4, 2022
Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells
Smit Kour, Sandeep Rana, Sydney P Kubica, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 25, 2021
Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax
Hannah M King, Sandeep Rana, Sydney P Kubica, et al.
Page
of 3